<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1008393.ref082">
 <label>82</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Altenburg</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Kreijtz</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>de Vries</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Song</surname>
   <given-names>F</given-names>
  </name>, 
  <name>
   <surname>Fux</surname>
   <given-names>R</given-names>
  </name>
  <etal>et al</etal>
  <article-title>Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases.</article-title>
  <source>Viruses</source>. 
  <year>2014</year>;
  <volume>6</volume>(
  <issue>7</issue>):
  <fpage>2735</fpage>â€“
  <lpage>2761</lpage>. 
  <pub-id pub-id-type="doi">10.3390/v6072735</pub-id> .
  <?supplied-pmid 25036462?>
  <pub-id pub-id-type="pmid">25036462</pub-id>
 </mixed-citation>
</ref>
